Skip to main content
Top
Published in: Acta Diabetologica 1/2019

01-01-2019 | Original Article

Autonomic testing: which value for each cardiovascular test? An observational study

Authors: Federico Bellavere, Eugenio Ragazzi, Nino Cristiano Chilelli, Annunziata Lapolla, Giuseppe Bax

Published in: Acta Diabetologica | Issue 1/2019

Login to get access

Abstract

Aims

Cardiovascular autonomic testing is time consuming when adopting the entire Ewing battery of tests, hence, clinicians usually adopt an empirically reduced number of tests which may give controversial results. Our purpose was to examine the reliability of the cardiovascular tests most commonly used in autonomic diagnoses.

Methods

We tested 334 subjects, from an original group of 3745, who had shown an altered deep breathing test to both Lying to standing and Valsalva manoeuvre, assuming a value of postural hypotension of more than 15 mmHg as a sign of almost true dysautonomia.

Results

VM showed the highest sensitivity (85%) and, when coupled to LS, highest specificity (83%).

Conclusions

VM could be useful when screening for possible or early autonomic neuropathy, VM + LS is useful as a diagnostic tool for probable or advanced autonomic neuropathy, and VM + LS + PH is useful for certain diagnosis of definite or late stage autonomic neuropathy.
Literature
1.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRef
2.
go back to reference Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 8:584–586.CrossRef Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 8:584–586.CrossRef
3.
go back to reference Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropahy. Br Med J. 285:916–918CrossRef Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropahy. Br Med J. 285:916–918CrossRef
4.
go back to reference Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M (1983) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 287:61CrossRef Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M (1983) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 287:61CrossRef
5.
go back to reference Spallone V, Bellavere F, Scionti L et al (2010) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21:69–78CrossRef Spallone V, Bellavere F, Scionti L et al (2010) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21:69–78CrossRef
6.
go back to reference Bellavere F (1995) Heart rate variability in patients with diabetes and other non cardiological diseases. In: Malik M, Camm AJ (eds) Heart rate variability. Futura Publishing Co., Armonk, pp 507–516 Bellavere F (1995) Heart rate variability in patients with diabetes and other non cardiological diseases. In: Malik M, Camm AJ (eds) Heart rate variability. Futura Publishing Co., Armonk, pp 507–516
7.
go back to reference Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603CrossRefPubMed Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603CrossRefPubMed
9.
go back to reference Lykke JA, Tarnow L, Parving H-H, Hilsted J (2008) A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scan J Clin Lab Invest 68:654–659CrossRef Lykke JA, Tarnow L, Parving H-H, Hilsted J (2008) A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scan J Clin Lab Invest 68:654–659CrossRef
10.
go back to reference Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. J Am Med Assoc 301:1547–1555CrossRef Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. J Am Med Assoc 301:1547–1555CrossRef
11.
go back to reference (1983) Editorial: diabetic neuropathy: where are we now? Lancet:1366–1367 (1983) Editorial: diabetic neuropathy: where are we now? Lancet:1366–1367
12.
go back to reference Bellavere F, Balzani I, De Masi G et al (1991) Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633–640CrossRef Bellavere F, Balzani I, De Masi G et al (1991) Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633–640CrossRef
13.
go back to reference Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef
14.
go back to reference Tang ZH, Wang L, Zeng F et al (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short term heart rate variability without a gold standard. BMJ Open 4(9):e005096CrossRefPubMedPubMedCentral Tang ZH, Wang L, Zeng F et al (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short term heart rate variability without a gold standard. BMJ Open 4(9):e005096CrossRefPubMedPubMedCentral
15.
16.
go back to reference Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476CrossRefPubMedPubMedCentral Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476CrossRefPubMedPubMedCentral
17.
go back to reference Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807CrossRefPubMedPubMedCentral Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807CrossRefPubMedPubMedCentral
Metadata
Title
Autonomic testing: which value for each cardiovascular test? An observational study
Authors
Federico Bellavere
Eugenio Ragazzi
Nino Cristiano Chilelli
Annunziata Lapolla
Giuseppe Bax
Publication date
01-01-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1215-y

Other articles of this Issue 1/2019

Acta Diabetologica 1/2019 Go to the issue